- Home
- VRTS vs BCRX Comparison
VRTS vs BCRX Comparison
Compare VRTS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRTS
- BCRX
- Stock Information
- Founded
- VRTS 1988
- BCRX 1986
- Country
- VRTS United States
- BCRX United States
- Employees
- VRTS N/A
- BCRX N/A
- Industry
- VRTS Investment Managers
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VRTS Finance
- BCRX Health Care
- Exchange
- VRTS Nasdaq
- BCRX Nasdaq
- Market Cap
- VRTS 1.3B
- BCRX 1.4B
- IPO Year
- VRTS 1992
- BCRX 1994
- Fundamental
- Price
- VRTS $162.75
- BCRX $7.21
- Analyst Decision
- VRTS Hold
- BCRX Strong Buy
- Analyst Count
- VRTS 5
- BCRX 11
- Target Price
- VRTS $184.00
- BCRX $19.00
- AVG Volume (30 Days)
- VRTS 79.3K
- BCRX 7.9M
- Earning Date
- VRTS 10-24-2025
- BCRX 11-03-2025
- Dividend Yield
- VRTS 5.84%
- BCRX N/A
- EPS Growth
- VRTS 18.44
- BCRX N/A
- EPS
- VRTS 19.47
- BCRX N/A
- Revenue
- VRTS $878,336,000.00
- BCRX $599,816,000.00
- Revenue This Year
- VRTS N/A
- BCRX $41.57
- Revenue Next Year
- VRTS $0.06
- BCRX $6.25
- P/E Ratio
- VRTS $8.44
- BCRX N/A
- Revenue Growth
- VRTS N/A
- BCRX 45.38
- 52 Week Low
- VRTS $142.18
- BCRX $6.00
- 52 Week High
- VRTS $252.82
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- VRTS 31.92
- BCRX 50.43
- Support Level
- VRTS $158.69
- BCRX $6.84
- Resistance Level
- VRTS $183.04
- BCRX $7.22
- Average True Range (ATR)
- VRTS 5.66
- BCRX 0.27
- MACD
- VRTS -0.23
- BCRX 0.03
- Stochastic Oscillator
- VRTS 14.68
- BCRX 71.87
About VRTS Virtus Investment Partners Inc.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.